SAUL B. GILSON, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The report on the symposium on prostatic cancer (in the editorial section of the October 1974 issue, Annals of Internal Medicine) describes a "goal of improved early detection." If this goal is reached, it will place the clinician in a terrible quandary. Clinical cancer of the prostate is relatively rare. Yet "35% of all men over 50 have microfoci of prostatic cancer" (1). Thus, most of these cases remain safer undiagnosed. It would seem that "ripeness is all" and early intervention ill advised. Indeed, the prevalence of an indefinitely quiescent cancer suggests a need for reevaluation of
GILSON SB. Prostatic Cancer. Ann Intern Med. 1975;82:427–428. doi: 10.7326/0003-4819-82-3-427_2
Download citation file:
Published: Ann Intern Med. 1975;82(3):427-428.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use